Renalytix plc Cash and Cash Equivalents
Renalytix plc (RENXF) had Cash and Cash Equivalents of $909.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2024-11-19
- 2024-09-30: Cash and Cash Equivalents, at Carrying Value $909.00K.
- 2024-06-30: Cash and Cash Equivalents, at Carrying Value $4.68M.
- 2024-03-31: Cash and Cash Equivalents, at Carrying Value $4.70M.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $5.62M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2024-09-30 | $909.00K 10-Q · filed 2024-11-19 |
| 2024-06-30 | $4.68M 10-Q · filed 2024-11-19 |
| 2024-03-31 | $4.70M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $5.62M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $13.89M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $24.68M 10-K · filed 2024-09-30 |
| 2023-03-31 | $33.03M 6-K · filed 2023-06-09 |
| 2022-12-31 | $23.82M 6-K · filed 2023-03-30 |
| 2022-09-30 | $31.04M 6-K · filed 2022-11-30 |
| 2022-06-30 | $41.33M 10-K · filed 2023-09-28 |
| 2022-03-31 | $32.36M 6-K · filed 2022-06-30 |
| 2021-12-31 | $39.93M 6-K/A · filed 2022-04-29 |
| 2021-06-30 | $65.13M 20-F · filed 2022-10-31 |
| 2020-06-30 | $13.29M 20-F/A · filed 2022-08-01 |
| 2019-06-30 | $8.20M 20-F/A · filed 2022-08-01 |
| 2018-06-30 | $82.00K 20-F · filed 2021-10-21 |